

SynBioBeta Speaker
Gabriele Corso
Boltz
CEO
Gabriele received his PhD from MIT CSAIL where his research focused on developing novel ML frameworks to tackle challenging problems in drug discovery and he led the development of popular models in the space including DiffDock, Boltz-1 and Boltz-2.
All Categories





































































































































